History
Stanford Vascular Surgery’s history is shaped by generations of faculty, trainees, researchers, and staff committed to advancing vascular care. Through continued innovation in surgery, research, and education, the division has grown while carrying forward a tradition of collaboration and excellence. Explore the milestones and people who have helped define our program and continue to influence its future.
Emile Holman, MD - founding Chair of Surgery at Stanford.
The Foundations of Vascular Surgery at Stanford
Stanford’s legacy in vascular surgery reaches back to the earliest years of the Department of Surgery and the specialty itself. Dr. Emile Frederic Holman became Stanford’s founding chair of surgery in 1926, and his early scientific contributions to the understanding and treatment of vascular disease helped establish a tradition of surgical inquiry and innovation at this institution. In recognition of his services to the development of the specialty, Dr. Holman became the third president of the Society for Vascular Surgery (SVS), the world’s oldest and most prestigious organization dedicated to the development of vascular surgery as a distinct specialty, in 1949. The modern clinical and administrative identity of Stanford Vascular Surgery, however, would take shape more than six decades after Dr. Holman assumed his chairmanship of the Department.
Early Pioneers and Landmark Contributions
Other early pioneers in vascular surgery at Stanford included Dr. Roy Cohn, the inaugural Chidester Professor of Surgery at Stanford, and Dr. Samuel Kountz - a Black surgical resident at Stanford. Both Drs. Cohn and Kountz were seminal contributors to the development of vascular physiologic measurement and surgical techniques, skills that later helped them develop some of the nation’s earliest and highest profile kidney transplant programs at Stanford and UCSF, respectively. In the case of Dr. Kountz specifically, he was the first Black surgeon to present a paper before the Society for Vascular Surgery, at the 16th annual meeting in Chicago in June of 1962. Dr. Cohn was his collaborator and sponsor for that paper, entitled: “Factors responsible for acute tubular necrosis following lower aortic surgery”. These presentations were particularly prestigious at that time as membership and participation in the SVS was strictly by invitation of the management committee.
Samuel Kountz, MD and Roy Cohn, MD
The Path to a Dedicated Vascular Surgery Division
Specialty board certification in vascular surgery (through the American Board of Surgery) was initiated in 1983, and by the mid-1980s, multiple academic departments of surgery across the nation were offering fellowship training in vascular surgery to board-eligible or board-certified vascular surgeons. The Vascular Surgery Division at Stanford was founded in 1993. Through the preceding two decades, major aortic reconstructive procedures in the chest and abdomen were primarily performed by cardiac surgeons (in the Department of Cardiac Surgery), while community vascular surgeons associated with Dr. Thomas Fogarty’s group at Sequoia Hospital—including Drs. John Mehigan and Cornelius Olcott (both trained at UCSF)—provided much of the region’s broader vascular care. The strength and quality of the surgical services provided by both these groups, essential as they were to the health and well-being of patients with vascular disease seeking care at Stanford, delayed the development of a Stanford-specific vascular surgical practice for many years.
Division Milestones
1926
Dr. Emile Holman becomes Stanford’s first chair of surgery and contributes to the broader development of vascular surgery.
Before 1992
Stanford does not have a formal vascular surgery division within the Department of Surgery. Major aortic procedures are performed by cardiac surgeons, while community vascular surgeons affiliated with Dr. Thomas Fogarty’s group—including Drs. John Mehigan and Cornelius Olcott—provide much of the broader vascular care.
1992
Department of Surgery Chair John Niederhuber works with cardiac surgery chair Bruce Reitz to reorganize services. Noncardiac thoracic surgery moves to cardiac surgery, while vascular surgery becomes part of the Department of Surgery. Dr. Ronald Dalman joins Stanford.
1993
Dr. Christopher Zarins becomes chief of Vascular Surgery and begins building the academic program.
Mid-1990s
Stanford recruits Drs. Cornelius Olcott and Thomas Fogarty. The division develops a close relationship with Fogarty Engineering and Silicon Valley’s medical-device community.
Mid-to-late-1990s
Stanford clinicians and engineers experiment with fabrics and device designs intended to improve endovascular aortic aneurysm repair.
September 1999
The AneuRx and Ancure endograft systems receive FDA approval, helping usher in the modern era of endovascular abdominal aortic aneurysm repair. FDA approval record.
1999-Early-2000s
Stanford hosts endovascular symposia, live demonstrations, and hands-on instruction for surgeons learning to use the new technology. 1999 Stanford Endovascular Symposium.
2005
Dr. Dalman succeeds Dr. Zarins as chief and leads the division through 2021.
2008
Stanford launches its integrated 0+5 vascular surgery residency and matches its first resident, Dr. George Lee. Stanford Vascular Surgery Residency Program.
2015
Stanford begins providing vascular surgery services at Santa Clara Valley Medical Center, expanding patient care and trainee experience.
July 2021
Dr. Jason Lee becomes chief of the Division of Vascular Surgery. Stanford leadership announcement
Fall 2021
The Baszucki Family Biobank is established to support translational and personalized vascular research. Biobank history
Present
The division continues to advance vascular care through open and endovascular surgery, vascular medicine, multidisciplinary clinical programs, research, and surgical education.